Vimentin, one of type III intermediate ®lament (IF) proteins, is expressed not only in mesenchymal cells but also in most types of tumor cells. In the present study, we introduced several types of vimentin mutated at putative phosphorylation sites in its amino-terminal head domain into type III IF-negative T24 cells. Site-speci®c mutation induced the formation of an unusually long bridge-like IF structure between the unseparated daughter cells, although these mutants formed the ®lament network similar to wild type in interphase cells. Together with sites phosphorylated by Rho-kinase and protein kinase C (PKC), vimentin-Ser72, which can not be phosphorylated by any known vimentin kinase, was one of the mutation sites essential for this phenotype. We further demonstrated that vimentin-Ser72 was phosphorylated speci®cally at the cleavage furrow during cytokinesis. These observations suggest the existence of a novel protein kinase responsible for vimentin ®lament separation through the cleavage furrow-speci®c vimentin phosphorylation. We propose that Rho-kinase, PKC, and an unidenti®ed vimentin-Ser72 kinase may play important roles in vimentin ®lament separation during cytokinesis. Oncogene (2001) 20, 2868 ± 2876.
Introduction
Mitosis is characterized by two distinct cytoskeletal structures, which appear transiently. The ®rst to form is a bipolar mitotic spindle, composed of microtubules and their associated proteins. It plays an active role in chromosome segregation (nuclear division). The second is a contractile ring, composed of actin ®laments and myosin II just beneath the plasma membrane, that appears just after chromosome segregation. As the ring contracts, it pulls the membrane inward so as to divide the cell in two (cytokinesis), thereby ensuring that each daughter cell receives not only one complete set of chromosome but also half of the cytoplasmic constituents in the parental cell.
Intermediate ®laments (IFs), together with microtubules and actin ®laments, form the cytoskeletal framework in the cytoplasm of various eukaryotic cells, and are also present in nuclei as the major component of nuclear lamina. Unlike microtubules and actin ®laments, the protein components of IFs vary in a cell-, tissue-, and dierentiation-dependent manner. For example, glial ®brillary acidic protein (GFAP), one of type III IF proteins, is expressed speci®cally in astroglial cells. While, vimentin, another type III IF protein, is expressed in mesenchymal cells, in most types of cultured and tumor cells, and transiently in many cells during early stages of development (Steinert and Roop, 1988; Eriksson et al., 1992; Fuchs and Weber, 1994) . IFs are known to be reorganized dramatically during mitosis (Franke et al., 1982) . Several lines of evidence reveal that various types of IF proteins are hyperphosphorylated during mitosis (Evans and Flik, 1982; Celis et al., 1983) . In vitro studies revealed that the phosphorylation of IF proteins by various types of serine/threonine protein kinases induces disassembly of the ®lament structure (Inagaki et al., 1987 . These observations led to the notion that IFs are reorganized through phosphorylation of IF proteins during mitosis.
Detailed studies using site-and phosphorylation state-speci®c antibodies revealed that mitotic IF phosphorylation is spatio-temporally regulated by distinct protein kinase(s) (Inagaki et al., , 1997a Foisner, 1997; Ku et al., 1998) . The ®rst evidence was obtained in an analysis using these antibodies for four distinct sites on GFAP (Nishizawa et al., 1991; Matsuoka et al., 1992) . Ser8 phosphorylation of GFAP in glial cells began in the prometaphase, remained until metaphase, and declined gradually thereafter. The phosphorylation was observed to be diuse throughout the cytoplasm. On the other hand, phosphorylation of residues Thr7, Ser13, and Ser38 were spatially and temporally distinct, increasing in anaphase, maintained until telophase, and decreasing at the exit of mitosis, and this phosphorylation was localized speci®cally at the cleavage furrow. Cdc2 kinase was demonstrated to be responsible for the former phosphorylation, and Rho-kinase for the latter one (Matsuoka et al., 1992; Kosako et al., 1997 Kosako et al., , 1999 Yasui et al., 1998; Goto et al., 2000) .
We produced a mutant GFAP in which each kinase phosphorylation site(s) are changed to an Ala residue(s) and introduced the mutant GFAP into type III IF-negative T24 cells. The expression of GFAP mutated at Rho-kinase phosphorylation sites impaired cytokinetic segregation of GFAP ®laments, the result being formation of an unusually long bridge-like structure (referred to as IF bridge) between unseparated daughter cells. Alteration of other sites, including a Cdc2 kinase phosphorylation site, led to no remarkable defect in GFAP ®lament separation (Yasui et al., 1998) . Therefore, GFAP phosphorylation by Rho-kinase may be required for separation of GFAP ®laments into daughter cells.
Vimentin, the most widely expressed IF protein described above, is also phosphorylated by several types of mitotic protein kinases, including Cdc2 kinase, protein kinase C (PKC), and Rho-kinase (Chou et al., 1990; Tsujimura et al., 1994; Takai et al., 1996; Goto et al., 1998) . However, little is known of the mechanism by which vimentin ®laments are eectively separated into two daughter cells. We postulated a mechanism functioning through mitotic vimentin phosphorylation and a mutational study was done. Mutation at Ser72 and at sites phosphorylated by Rho-kinase and protein kinase C (PKC) was necessary for the majority of transfected cells to show the IF bridge phenotype. In addition, vimentin-Ser72, which can not be phosphorylated by any identi®ed vimentin kinases, was demonstrated to be phosphorylated speci®cally at the cleavage furrow during cytokinesis.
Results
We reported that Rho-kinase phosphorylated type III IF proteins, including GFAP and vimentin, speci®cally at the cleavage furrow during cytokinesis (Kosako et al., 1997 (Kosako et al., , 1999 Goto et al., 1998; Inada et al., 1999) . In the case of GFAP, this phosphorylation was required for glial ®lament separation into daughter cells: mutation in Rho-kinase phosphorylation sites induced the formation of an unusually long bridge-like structure (referred to as IF bridge) between unseparated daughter cells (Yasui et al., 1998 ; also see Figure 1 ). To determine if there is a similar mechanism for vimentin ®lament separation, we transiently expressed vimentin mutated at Ser38 and Ser71, Rho-kinase phosphorylation sites (Goto et al., 1998) Figure 1a and Table 1 ). Since about 60 ± 70% of transfected cells formed the IF bridge in the case of GFAP mutation (Yasui et al., 1998 ; also see Table 1 ), there may be dierent mechanisms by which vimentin ®laments are eectively separated into two daughter cells.
Mitotic vimentin phosphorylation may possibly be regulated at least by the following four types of protein kinases: (1) Cdc2 kinase phosphorylated vimentin in the entire cytoplasm from entry into mitosis to metaphase (Chou et al., 1990; Tsujimura et al., 1994) ; (2) PKC phosphorylated the entire vimentin by mitotic reorganization of intracellular membrane systems and the interaction of vesicles with vimentin ®laments. This phosphorylation increased at prometaphase/metaphase, was maintained until anaphase, and decreased in telophase (Takai et al., 1996) ; (3) Rho-kinase phosphorylated vimentin speci®cally at the cleavage furrow during cytokinesis (Goto et al., 1998; Kosako et al., 1999) and (4) CaM kinase II phosphorylation sites (Ser38 and Ser82), were slightly phosphorylated in the entire cytoplasm during interphase and increasingly during mitosis. Figure 1b summarizes vimentin phosphorylation at various sites in each stage of mitosis: Ser33, Ser55, Ser71, or Ser82 was identi®ed as a unique site for PKC, Cdc2 kinase, Rho-kinase, or CaM kinase II among known vimentin kinases, respectively: Ser6 and Ser50 as PKC phosphorylation sites: Ser38 as a site for PKC, Rho-kinase, and CaM kinase II. These observations led to the notion that vimentin ®lament separation may also be regulated through mitotic vimentin phosphorylation, although Rho-kinase may not be the only regulating kinase for separating vimentin ®laments during cytokinesis.
Next, we constructed a set of vimentin mutants in which phosphorylation sites by one or more known vimentin kinase(s) are changed into Ala (indicated in Table 1 ) and we transiently expressed these mutants in T24 cells. However, few cells formed IF bridge in postmitotic cells transfected with each mutant form of vimentin: only 3.2% even in cells transfected with vimentin mutated at sites by all known vimentin kinases (Rho-kinase, PKC, CaM kinase II, and Cdc2 kinase; Table 1 ). Thus, we postulate the existence of an unknown protein kinase(s) which may phosphorylate vimentin at a site(s) other than known phosphorylation ones and may be responsible for vimentin ®lament separation. Biochemical analysis using 32 P-labeled mitotic cells revealed that vimentin was phosphorylated only at serine residues during mitosis (Evans, 1984) , and we also obtained similar results (data not shown). So, we produced another set of vimentin mutants in which all known vimentin kinase sites and an additional serine residue were altered (indicated in Table 2 ). Among these mutations, vimentin mutation at Ser72 in addition to all known kinase sites induced a remarkable phenotype on ®lament separation. Many cells transfected with this mutant (60.2% cells relative to the total number of transfected postmitotic cells; (Figure 2 ), as we had observed in the case of GFAP mutation at Rho-kinase phosphorylation sites (Yasui et al., 1998 ; also see Figure 1a and Table 1 ). However, another mutant form of vimentin, in which Ser21, Ser28, Ser46, or Ser64 is altered in addition to all kinase sites, showed no remarkable increase in IF bridge formation (Table 2 ). These results suggested that this phenotype may be induced by the site-speci®c mutation on vimentin, and that the Ser72 mutation is required for many transfected cells to form an IF bridge between daughter cells.
To determine the mutation sites essential for formation of the IF bridge on vimentin ®laments, we prepared a series of vimentin mutated at sites by one or two known vimentin kinase(s) in addition to Ser72. As shown in Table 3 , mutation at sites phosphorylated by Rho-kinase and PKC in addition to Ser72 seemed to be an alternative to that at Ser72 and all known vimentin kinase sites: there was no remarkable dierence in the population of IF bridge-forming cells between the two mutants. However, the other set of mutations had a much lesser eect on formation of the IF bridge, compared with mutation at Ser72 and all known vimentin kinase sites (Table 3 ). All these observations suggest that vimentin mutation at Ser72 and at sites phosphorylated by Rho-kinase and PKC is a prerequisite for a high percentage of cells to show the IF bridge phenotype.
To rule out the possibility that vimentin mutation in the amino-terminal head domain might aect the structure of this region and thereby induce IF bridge, we ®rst observed cells expressing the above mutants carefully. Figure 3 indicates the expression pattern of wild type vimentin or each vimentin mutant in interphase cells. These patterns are indistinguishable: in most transfected cells, each mutant appears to form the normal ®lament network. There was no dierence in mitotic cell morphology and population between wild type and each mutant (data not shown). Next, we cotransfected vimentin mutated at Ser72 and at sites phosphorylated by Rho-kinase and PKC with wild type vimentin at the ratio of 1 : 1. Only 1 ± 2% cells showed the IF bridge phenotype in cotransfected cells (data not shown), although about 60% cells did in cells transfected with this mutant alone (Tables 2 and 3) . These results suggested that IF bridge phenotype may be induced by the blockade of site-speci®c vimentin phosphorylation during mitotic process rather than by the change of the ®lament structure. However, vimentin-Ser72, one of the key mutation sites, was reported to be not phosphorylated by any known vimentin kinase, such as PKC, Cdc2 kinase, Rho-kinase, and CaM kinase II. So, mutational analyses raised the question of whether vimentinSer72 is phosphorylated in intact cells (especially during mitosis). Then, we produced a site-and phosphorylation state-speci®c antibody for this site (referred to as YG72), using the synthetic phosphopeptide PV72 (Figure 4a ) corresponding to vimentin phosphorylation at Ser72. Figure 4a shows the speci®city of YG72, as determined by ELISA. YG72 had a very high anity for PV72, but much less anity for PV71 or unphosphorylated peptides V71 and V72 (Figure 4a ). Therefore, YG72 may immunoreact speci®cally with vimentin phosphorylated at Ser72 but not at Ser71. Figure 4b ,c show U251 glioma cells immunostained with YG72. The immunoreactivity was observed speci®cally at the cleavage furrow in cytokinetic cells (an arrow in Figure 4b,c) . No immunoreactivity was observed in early mitotic cells (an arrow head in Figure 4b ,c) or in interphase cells (Figure 4b ). The immunoreactivity of YG72 appeared at the onset of anaphase, was maintained until telophase, and decreased at the exit of mitosis ( Figure  4c ). These results suggested that there may exist a novel protein kinase which phosphorylates at least Ser72 on vimentin speci®cally at the cleavage furrow during cytokinesis. This kinase might be responsible for vimentin ®lament separation during mitotic process, together with Rho-kinase and PKC.
Discussion
In this study, we demonstrated that site-speci®c mutation of vimentin induced the formation of IF bridge between the unseparated daughter cells. In addition to phosphorylation sites of Rho-kinase and PKC, vimentin-Ser72, which can not be phosphory- (6, 20, 24, 25, 33, 38, 41, 50, 65, 82) 200 6.3+0.6 3.2+0.3 PKC+Cdc2 kinase mutant (6, 20, 24, 25, 33, 38, 41, 50, 55, 65) 200 7.3+5.5 3.7+2.8 CaM-K II+Cdc2 kinase mutant (38, 41, 55, 82) 200 1.3+2.3 0.7+1.2 Rho-K+PKC+CaM-K II mutant (6, 20, 24, 25, 33, 38, 41, 50, 65, 71, 82) 200 7.3+2.3 3.7+1.2 Rho-K+PKC+Cdc2 kinase mutant (6, 20, 24, 25, 33, 38, 41, 50, 55, 65, 71) 200 5.0+4.6 2.5+2.3 Rho-K+CaM-K II+Cdc2 kinase mutant (38, 41, 55, 71, 82) 200 1.0+1.7 0.5+0.9 PKC+CaM-K II+Cdc2 kinase mutant (6, 20, 24, 25, 33, 38, 41, 50, 55, 65, 82) 200 4.3+0.6 2.2+0.3 Rho-K+PKC+CaM-K II+Cdc2 kinase mutant (6, 20, 24, 25, 33, 38, 41, 50, 55, 65, 71, 82) 200 6.3+8.4 3.2+4.2
The results are expressed as the mean+s.d. of three independent experiments. At least 200 cells per each sample were counted 6 (6,20,24,25,33,38,41,50,55,65,71,72,82) The results are expressed as the mean+s.d. of three independent experiments. At least 200 cells per each sample were counted Oncogene Phosphorylation-dependent segregation of vimentin filaments Y Yasui et al lated by any identi®ed vimentin kinases, was found to be one of the key mutation sites for the majority of transfected cells to show this phenotype. Furthermore, using a site-and phosphorylation state-speci®c antibody, we demonstrated that vimentin-Ser72 was phosphorylated speci®cally at the cleavage furrow during cytokinesis.
The IF network is known to be segregated into two daughter cells before ®nal separation. Our mutational studies provide a key to understand mechanisms governing this IF segregation. In the case of GFAP (Yasui et al., 1998 ; also see Figure 1a ) and vimentin (Figure 2 ), mutation of putative phosphorylation sites in their head domain impaired cytokinetic IF segregation: the IF bridge phenotype was induced by the sitespeci®c mutation on these IF proteins. These observations suggested that site/domain-speci®c IF protein phosphorylation is required for IF separation in the case of GFAP and vimentin. In other types of IF proteins, phosphorylation by various types of protein kinases is also reported to occur mainly in the head domain on IF proteins, and to induce disassembly of the ®lament structure, in vitro . Therefore, our ®ndings in GFAP and vimentin led to the proposal of a common mechanism governing IF separation via the site/domain-speci®c IF protein phosphorylation during mitosis.
However, protein kinase(s) regulating IF segregation may depend on the type of IF proteins. In the case of GFAP, triphosphorylation at Rho-kinase phosphorylation sites was required for ecient IF separation (Yasui et al., 1998) . On the other hand, vimentin mutation at sites by each single kinase including Rhokinase had little eect on IF bridge formation ( Figure  1a and Table 1 ). Mutation of vimentin at Ser72 and at sites phosphorylated by Rho-kinase and PKC had eects similar to that of GFAP at all three Rho-kinase sites (Tables 2 and 3 ). These mutational analyses led us Rho-K+PKC+CaM-K II+Cdc2 kinase+72 mutant (6, 20, 24, 25, 33, 38, 41, 50, 55, 65, 71, 72, 82 ) 100 72 mutant (72) 0.0 CaM-K II+72 mutant (38, 82, 72) 0.3 Cdc2 kinase+72 mutant (41, 55, 72) 1.8 PKC+72 mutant (6, 20, 24, 25, 33, 38, 41, 50, 65, 72) 42.6 Rho-K+72 mutant (38, 71, 72) 5.5 CaM-K II+Cdc2 kinase+72 mutant (38, 41, 55, 72, 82) 5.5 PKC+CaM-K II+72 mutant (6, 20, 24, 25, 33, 38, 41, 50, 65, 72, 82) 41.5 PKC+Cdc2 kinase+72 mutant (6, 20, 24, 25, 33, 38, 41, 50, 55, 65, 72) 45.0 Rho-K+CaM-K II+72 mutant (38, 71, 72, 82) 7.6 Rho-K+Cdc2 kinase+72 mutant (38, 41, 55, 71, 72) 9.7 Rho-K+PKC+72 mutant (6, 20, 24, 25, 33, 38, 41, 50, 65, 71, 72) 98.5
Populations of cells with IF bridges relative to that of Rho-K+PKC+CaM-K II+Cdc2 kinase+72 mutant were scored. The results are expressed as the mean of three independent experiments. In each experiment, at least 200 cells were counted to propose that Rho-kinase, PKC, and an unidenti®ed vimentin-Ser72 kinase may play important roles in vimentin ®lament separation. Our observations also raised the question of how important each kinase is in the ®lament separation. Mutational analyses provide some hints. Mutation at Ser72 and at sites phosphorylated by Rho-kinase and PKC had relatively full eect in IF bridge formation (Table 3) . However, neither mutation at Rho-kinase+PKC phosphorylation sites nor that at Rho-kinase phosphorylation sites+Ser72 had any eect (Tables 1   and 3 ). These results implied that the single protein kinase (i.e., a vimentin-Ser72 kinase or PKC) could phosphorylate vimentin at the level necessary for the ®lament separation. In other words, a vimentin-Ser72 kinase or PKC may be alone sucient for segregation of vimentin ®laments. Since mutation at PKC phosphorylation sites+Ser72 had half eect (Table  3) , Rho-kinase might be necessary but not alone sucient for the ®lament separation.
PKC is thought to play important roles not only in signal transduction but also in cell cycle control: (Nishizuka, 1992; Livneh and Fishman, 1997) . Some PKC isoforms were also demonstrated to be mitotically activated (Goss et al., 1994; Thompson and Fields, 1996; Passalacqua et al., 1999) , but mitotic PKC function remained largely unknown. We previously demonstrated that PKC phosphorylated vimentin by mitotic reorganization of intracellular membrane systems and the interaction of vesicles with vimentin ®laments (Takai et al., 1996) . Our present study indicated that PKC might regulate the segregation of vimentin ®laments through this mitosis-speci®c phosphorylation. Interestingly, PKC was also found to be required for nuclear lamina disassembly, likely through the phosphorylation of lamin B1 (Goss et al., 1994; Thompson and Fields, 1996) . Therefore, one of mitotic PKC functions may be the reorganization of cytoplasmic and nuclear IF network through IF protein phosphorylation.
The detection of vimentin-Ser72 kinase activity in late mitotic cells raises the question of the identity of the kinase. The speci®c localization of this kinase activity suggests the possibility that it may play some important roles in cytokinesis. Accumulating evidence suggests that Rho family proteins, such as Cdc42, Rac, and Rho, may be required for cytokinesis Hall, 1998; Prokopenko et al., 2000) . Among known protein kinases downstream of Rho family proteins, Rho-kinase, citron kinase, and p21-activated kinase (PAK) were found to be required for cytokinesis (Yasui et al., 1998; Madaule et al., 1998; Chung and Firtel, 1999; Holly and Blumer, 1999) . However, the constitutively active form of Rho-kinase and citron kinase can not phosphorylate vimentin-Ser72 in COS7 cells (data not shown). So, the vimentin-Ser72 kinase appears to be neither Rho-kinase nor citron kinase. PAK can phosphorylate vimentin at Ser72 but not at Ser71 in vitro (L Lim and M Inagaki, unpublished observation). However, our immunocytochemical analyses using several types of anti-PAK antibodies revealed that PAK might be distributed diusely in cytoplasm during cytokinesis (data not shown), unlike Rho-kinase and citron kinase which were concentrated at the cleavage furrow (Kosako et al., 1999; Madaule et al., 1998) . So, PAK might not be a candidate for vimentin-Ser72 kinase. Recently, one of mammalian homologs of Drosophila Aurora and yeast Ipl1p, a serine/threonine kinase AIM-1 (also called ARK2, Aik2, aurora1 and STK12; Bischo and Plowman, 1999) was demonstrated to localize to the spindle midzone. Overexpression of kinase-inactive AIM-1 disrupts cleavage furrow formation, resulting in cell polyploidy (Terada et al., 1998) . These results are strikingly similar to those found on disruption of AIR-2, the Caenorhabditis elegans ortholog of AIM-1 (Schumacher et al., 1998) . Interestingly, AIM-1 phosphorylated vimentin at Ser72 in vitro (H Goto, Y Yasui and M Inagaki, unpublished observation). In addition, recent evidence also implicates mammalian Polo-like kinases (Plks), homologs of other Drosophila mitotic serine/threonine kinase Polo, in controlling multiple stages of mitosis. Genetic and biochemical studies point to additional roles for Plks in cytokinetic process (Lane and Nigg, 1997; Nigg, 1998) , suggesting the possibility that Plks may function as a vimentinSer72 kinase.
In conclusion, we found that vimentin mutation at Ser72 and at sites phosphorylated by Rho-kinase and PKC impairs segregation of vimentin ®laments. Using a site-and phosphorylation state-speci®c antibody, we demonstrated the existence of a novel protein kinase which phosphorylates at least Ser72 on vimentin speci®cally at the cleavage furrow during cytokinesis. We propose that PKC, Rho-kinase and an unidenti®ed vimentin-Ser72 kinase may play important roles in vimentin separation through the site/domain-speci®c vimentin phosphorylation. The identi®cation of this vimentin-Ser72 kinase will help to elucidate the molecular mechanism not only of mitotic IF segregation but also of cytokinetic process. These issues will be addressed in the future studies.
Materials and methods

Gene construction
For expression of wild-type vimentin, cDNA for mouse vimentin (Ogawara et al., 1995) was introduced in the expression vector pDR2 (Clontech, Palo Alto, CA, USA).
Mutations to vimentin cDNA were constructed using a PCRbased mutagenesis procedure, as described (Yasui et al., 1998) . The mutation sites were con®rmed by sequencing using the dideoxy termination method and a DNA sequencer (Applied Biosystems, Foster City, CA, USA).
Transfection
EBNA-expressing T24 cells (Yasui et al., 1998) were maintained in DMEM supplemented with 10% FBS in a 378C, 5% CO 2 incubator. The cells were transiently transfected with wild-type vimentin, mutant vimentin or mutant GFAP cDNA (Yasui et al., 1998) in pDR2, using Lipofectamine (GIBCO/BRL, Gaithersburg, MD, USA) according to the manufacturer's protocol. Forty-eight hours after transfection, the mitotic cells were prepared, as described (Yasui et al., 1998) and incubated for 3 h on glass coverslips in fresh medium to allow for cell cycle progression. IF bridge formation was analysed, immunocytochemically.
Production of anti-PV72 antibody (YG72)
The vimentin peptides PV72, V72, PV71 and V71 ( Figure 4a ) were chemically synthesized by Peptide Institute Inc. (Osaka, Japan). Antibodies against PV72 were prepared by injecting two rabbits with PV72 coupled to keyhole limpet hemocyanin, mixed with RIBI adjuvant system R-730 (RIBI Immunochem Research). Monospeci®c antibodies against PV72 were puri®ed from the obtained serum by four-step chromatography: absorption in PV71-, V71-, and V72-coupled Cellulo®ne (Seikagaku Corp., Tokyo, Japan) and then anity chromatography on PV72-coupled Cellulo®ne. Protein concentrations of puri®ed antibodies were measured, according to the manufacturer's protocol, using bovine IgG as a standard (Bio-Rad, Hercules, CA, USA). Puri®ed anti-PV72 antibodies from two rabbits had almost the same immunoreactivity, thus, one of these antibodies was referred to as YG72 (0.2 mg/ml) and was used for the following experiments.
Immunocytochemistry
Cells growing on type I collagen-coated glass coverslips were ®xed with 3.7% formaldehyde in ice-cold PBS for 15 min and then treated with methanol at 7208C for 10 min. Incubation with primary antibodies diluted in PBS containing 10% normal goat serum was for 2 h at 378C. After three washes with PBS, cells were incubated for 1 h with appropriatē uorescent-conjugated secondary antibodies and subsequently washed with PBS. Then DNAs were stained with 0.5 mg/ml propidium iodide (Sigma) for 10 min, at room temperature.
The following antibodies were used for indirect immunocytochemistry; for detection of GFAP ®lament and vimentin ®lament, MO389 (anti-GFAP) mouse mAb (Sekimata et al., 1996) diluted 1 : 20, anti-vimentin goat polyclonal antibodies diluted 1 : 1000, FITC-conjugated goat anti-mouse immunoglobulins (Bio-Source International, Camarillo, CA, USA) diluted 1 : 200, and FITC-conjugated rabbit anti-goat immunoglobulins (American Qualex); for detection of sitespeci®c phosphorylation of vimentin, MO6 (anti-phosphoSer6 of vimentin) mouse mAb (Inagaki et al., 1997b) diluted 1 : 2, YT33 (anti-phospho-Ser33) mouse mAb (Ogawara et al., 1995) diluted 1 : 2, TM38 (anti-phospho-Ser38) rat mAb (Kosako et al., 1999) diluted 1 : 2, TM50 (anti-phospho-Ser 50) rat mAb (Takai et al., 1996) diluted 1 : 2, 4A4 (antiphospho-Ser55) mouse mAb (Tsujimura et al., 1994) diluted 1 : 100, TM71 (anti-phospho-Ser71) rat mAb (Kosako et al., 1999) diluted 1 : 2, MO82 (anti-phospho-Ser82) mouse mAb (Ogawara et al., 1995) 
